Pulmonx Corporation

NASDAQ:LUNG

5.77 (USD) • At close February 4, 2025
Bedrijfsnaam Pulmonx Corporation
Symbool LUNG
Munteenheid USD
Prijs 5.77
Beurswaarde 227,845,183
Dividendpercentage 0%
52-weken bereik 5.46 - 14.835
Industrie Medical Devices
Sector Healthcare
CEO Mr. Glendon E. French
Website https://pulmonx.com

An error occurred while fetching data.

Over Pulmonx Corporation

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system

Vergelijkbare Aandelen

Editas Medicine, Inc. logo

Editas Medicine, Inc.

EDIT

1.29 USD

Theravance Biopharma, Inc. logo

Theravance Biopharma, Inc.

TBPH

9.43 USD

Deciphera Pharmaceuticals, Inc. logo

Deciphera Pharmaceuticals, Inc.

DCPH

25.59 USD

Replimune Group, Inc. logo

Replimune Group, Inc.

REPL

14.01 USD

Catalyst Pharmaceuticals, Inc. logo

Catalyst Pharmaceuticals, Inc.

CPRX

23.09 USD

IGM Biosciences, Inc. logo

IGM Biosciences, Inc.

IGMS

1.57 USD

Erasca, Inc. logo

Erasca, Inc.

ERAS

1.78 USD

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

TGTX

32.91 USD

DocGo Inc. logo

DocGo Inc.

DCGO

4.95 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)